---
schema_version: "secwatch.filing_event.v1"
accession: "0001801170-23-000024"
form_type: "8-K"
ticker: "CLOV"
cik: "0001801170"
company_name: "CLOVER HEALTH INVESTMENTS, CORP. /DE"
filed_at: "2023-04-21T23:59:59+00:00"
generated_at: "2026-06-16T21:34:26.105480+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Clover Health receives Nasdaq delisting notice for bid price below $1.00

## Summary
- Nasdaq notified Clover on April 20, 2023 that CLOV closed below $1.00 for 30 consecutive business days.
- Company has 180 calendar days, until October 17, 2023, to regain compliance by closing at $1.00+ for 10 consecutive days.
- May seek stockholder approval to effect a reverse stock split to regain compliance.
- If not compliant by Oct 17, may transfer to Nasdaq Capital Market for an additional 180-day cure period.

## SEC filing metadata
- accession: 0001801170-23-000024
- form_type: 8-K
- ticker: CLOV
- cik: 0001801170
- company_name: CLOVER HEALTH INVESTMENTS, CORP. /DE
- filed_at: 2023-04-21T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1801170/000180117023000024/0001801170-23-000024-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1801170/000180117023000024/clov-20230420.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001801170-23-000024
- JSON: https://secwatch.observer/filing/0001801170-23-000024.json
- Plain text: https://secwatch.observer/filing/0001801170-23-000024.txt

## Key facts
- Listing & Compliance Notices
  CLOVER HEALTH INVESTMENTS, CORP. /DE received a nasdaq deficiency notice notice regarding minimum bid price (rules 5450(a)(1), 5810(c)(3)(A)).
  - Exchange: nasdaq
  - Notice: deficiency notice
  - Deficiency: minimum bid price
  - Rules: 5450(a)(1), 5810(c)(3)(A)
  source text: April 20, 2023, Clover Health Investments, Corp. (the “Company”) received a written notice (the “Notice”) from The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that, for the last 30 consecutive business days, the bid price for the Company’s Class A common stock (the “Common Stock”) had closed below the $1.00 per share minimum bid price requirement for continued inclusion on The Nasdaq Global Select Market pursuant to Nasdaq Listing Rule 5450(a)(1) (the “Minimum Bid Price Requirement”). The Notice has no immediate effect on the listing of the Common Stock, which continues to trade o
  evidence_url: https://www.sec.gov/Archives/edgar/data/1801170/000180117023000024/0001801170-23-000024-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.